NASDAQ : COLL
Collegium Pharmaceutical, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 23.8 USD (Oct 30, 2026, 4:00 PM EST) · Market cap 774.82M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Collegium Pharmaceutical, Inc. (COLL) reported revenue of 808.21M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 808.21M | 780.57M | 631.45M | 566.77M | 463.93M | 276.87M |
| Cost of Revenue | 85.27M | 86.93M | 83.53M | 94.84M | 118.19M | 59.07M |
| Gross Profit | 722.93M | 693.64M | 547.92M | 471.93M | 345.74M | 217.80M |
| Selling, General & Admin | 321.91M | 278.66M | 182.98M | 150.71M | 172.19M | 118.96M |
| Research & Development | 3.98M | 9.45M | ||||
| Amortization of Goodwill & Intangibles | 229.37M | 221.89M | 165.30M | 145.76M | 131.47M | 67.18M |
| Operating Expenses | 551.28M | 500.55M | 348.29M | 296.47M | 307.64M | 195.59M |
| Operating Income | 171.65M | 193.09M | 199.63M | 175.46M | 38.10M | 22.21M |
| Interest Expense | -76.44M | -82.31M | -73.97M | -83.34M | -63.21M | -21.01M |
| Interest & Investment Income | 12.68M | 11.29M | 13.98M | 15.62M | 1.05M | 12.00K |
| EBT Excluding Unusual Items | 107.89M | 122.07M | 139.63M | 107.74M | -24.06M | 1.20M |
| Merger & Restructuring Charges | -9.23M | -9.61M | -29.60M | -4.58M | ||
| Asset Writedown | -575.00K | -575.00K | -4.79M | |||
| Legal Settlements | -3.06M | -3.06M | -8.50M | |||
| Other Unusual Items | -17.35M | -16.21M | -11.47M | -23.50M | ||
| Pretax Income | 77.68M | 92.62M | 98.57M | 75.73M | -28.85M | -3.37M |
| Income Tax Expense | 29.77M | 29.75M | 29.38M | 27.58M | -3.85M | -74.89M |
| Net Income | 47.91M | 62.87M | 69.19M | 48.16M | -25.00M | 71.52M |
| Net Income to Common | 47.91M | 62.87M | 69.19M | 48.16M | -25.00M | 71.52M |
| Shares Outstanding (Basic) | 31.94M | 31.71M | 32.27M | 33.74M | 33.83M | 34.94M |
| Shares Outstanding (Diluted) | 36.20M | 39.70M | 40.42M | 41.79M | 33.83M | 41.05M |
| EPS (Basic) | 1.50 | 1.98 | 2.14 | 1.43 | -0.74 | 2.05 |
| EPS (Diluted) | 1.41 | 1.73 | 1.86 | 1.29 | -0.74 | 1.86 |
| Free Cash Flow | 328.28M | 327.58M | 203.33M | 274.29M | 122.61M | 101.61M |
| Free Cash Flow Per Share | 9.07 | 8.25 | 5.03 | 6.56 | 3.62 | 2.48 |
| Gross Margin | 89.45% | 88.86% | 86.77% | 83.27% | 74.52% | 78.66% |
| Operating Margin | 21.24% | 24.74% | 31.61% | 30.96% | 8.21% | 8.02% |
| Profit Margin | 5.93% | 8.05% | 10.96% | 8.50% | -5.39% | 25.83% |
| Free Cash Flow Margin | 40.62% | 41.97% | 32.20% | 48.39% | 26.43% | 36.70% |
| EBITDA | 405.25M | 419.16M | 368.79M | 324.72M | 172.26M | 91.12M |
| EBITDA Margin | 50.14% | 53.70% | 58.40% | 57.29% | 37.13% | 32.91% |
| D&A For EBITDA | 233.60M | 226.07M | 169.16M | 149.26M | 134.15M | 68.92M |
| EBIT | 171.65M | 193.09M | 199.63M | 175.46M | 38.10M | 22.21M |
| EBIT Margin | 21.24% | 24.74% | 31.61% | 30.96% | 8.21% | 8.02% |
| Effective Tax Rate | 38.32% | 32.12% | 29.80% | 36.41% | ||
| Advertising Expenses | 27.78M | 10.66M | 7.41M | 11.74M | 4.19M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 129.47M | 231.25M | 70.56M | 238.95M | 173.69M | 186.43M |
| Short-Term Investments | 155.43M | 92.20M | 71.60M | |||
| Cash & Short-Term Investments | 129.47M | 386.68M | 162.76M | 310.55M | 173.69M | 186.43M |
| Receivables | 285.10M | 211.33M | 228.54M | 179.53M | 183.12M | 105.84M |
| Inventory | 113.27M | 40.91M | 35.56M | 32.33M | 46.50M | 17.39M |
| Prepaid Expenses | 60.33M | 26.93M | 21.94M | 11.05M | 11.49M | 5.85M |
| Restricted Cash | 19.85M | 19.85M | 25.00M | |||
| Other Current Assets | 5.72M | 8.45M | 4.15M | 5.20M | 27.00K | |
| Total Current Assets | 608.01M | 691.41M | 482.26M | 537.60M | 419.99M | 315.54M |
| Property, Plant & Equipment | 14.44M | 16.20M | 20.15M | 22.01M | 26.38M | 27.14M |
| Goodwill | 190.18M | 145.93M | 162.33M | 133.86M | 133.69M | |
| Other Intangible Assets | 1.19B | 669.51M | 891.40M | 421.71M | 567.47M | 268.72M |
| Long-Term Deferred Tax Assets | 120.77M | 112.54M | 98.03M | 26.26M | 23.95M | 78.04M |
| Other Long-Term Assets | 16.30M | 21.25M | 9.41M | 1.87M | 2.65M | 2.63M |
| Total Assets | 2.14B | 1.66B | 1.66B | 1.14B | 1.17B | 692.08M |
| Accounts Payable | 9.24M | 10.66M | 3.93M | 8.69M | 3.49M | 4.19M |
| Accrued Expenses | 282.18M | 227.32M | 251.55M | 185.26M | 193.07M | 167.75M |
| Current Portion of Long-Term Debt | 55.00M | 29.00M | 64.58M | 183.33M | 162.50M | 48.35M |
| Current Portion of Leases | 1.56M | 1.41M | 1.27M | 988.00K | 1.11M | 814.00K |
| Current Income Taxes Payable | 1.14M | 3.30M | 8.53M | 2.14M | 622.00K | |
| Current Unearned Revenue | 667.00K | 667.00K | ||||
| Other Current Liabilities | 240.08M | 167.67M | 179.64M | 77.50M | 73.55M | 57.84M |
| Total Current Liabilities | 589.86M | 440.03M | 509.51M | 457.92M | 433.73M | 279.57M |
| Long-Term Debt | 1.16B | 901.89M | 908.52M | 483.84M | 538.45M | 201.63M |
| Long-Term Leases | 3.41M | 4.13M | 5.54M | 6.12M | 7.11M | 7.95M |
| Long-Term Unearned Revenue | 8.78M | 9.11M | 10.00M | |||
| Other Long-Term Liabilities | 22.96M | 1.18M | ||||
| Total Liabilities | 1.82B | 1.36B | 1.43B | 947.88M | 979.29M | 489.15M |
| Common Stock | 41.00K | 41.00K | 40.00K | 38.00K | 37.00K | 36.00K |
| Additional Paid-In Capital | 636.06M | 624.95M | 590.25M | 565.95M | 538.07M | 502.10M |
| Retained Earnings | -101.68M | -101.13M | -164.00M | -233.19M | -281.34M | -256.34M |
| Treasury Stock | -222.51M | -222.51M | -197.50M | -137.38M | -61.92M | -42.86M |
| Comprehensive Income & Other | 319.00K | 55.00K | 14.00K | |||
| Shareholders' Equity | 311.91M | 301.68M | 228.84M | 195.43M | 194.84M | 202.93M |
| Total Liabilities & Equity | 2.14B | 1.66B | 1.66B | 1.14B | 1.17B | 692.08M |
| Total Debt | 1.22B | 936.43M | 979.91M | 674.28M | 709.17M | 258.75M |
| Net Cash (Debt) | -1.09B | -549.75M | -817.15M | -363.74M | -535.49M | -72.32M |
| Net Cash Per Share | -30.07 | -13.85 | -20.21 | -8.70 | -15.83 | -1.76 |
| Filing Date Shares Outstanding | 32.56M | 31.75M | 31.49M | 31.96M | 34.07M | 33.38M |
| Total Common Shares Outstanding | 32.50M | 31.71M | 31.44M | 31.87M | 33.85M | 33.66M |
| Working Capital | 18.15M | 251.38M | -27.25M | 79.69M | -13.74M | 35.98M |
| Book Value Per Share | 9.60 | 9.51 | 7.28 | 6.13 | 5.76 | 6.03 |
| Tangible Book Value | -1.06B | -513.76M | -824.89M | -360.13M | -506.32M | -65.80M |
| Tangible Book Value Per Share | -32.75 | -16.20 | -26.24 | -11.30 | -14.96 | -1.95 |
| Machinery | 25.58M | 25.83M | 24.60M | 24.97M | 18.46M | |
| Construction In Progress | 1.75M | 802.00K | 5.18M | |||
| Leasehold Improvements | 1.23M | 1.23M | 1.06M | 874.00K | 541.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 47.91M | 62.87M | 69.19M | 48.16M | -25.00M | 71.52M |
| Depreciation & Amortization | 233.60M | 226.07M | 169.16M | 149.26M | 134.15M | 68.92M |
| Other Amortization | 4.52M | 5.34M | 6.02M | 8.63M | 8.29M | 3.41M |
| Asset Writedown & Restructuring Costs | 4.79M | |||||
| Loss (Gain) From Sale of Investments | -707.00K | -1.07M | -2.03M | -1.24M | ||
| Stock-Based Compensation | 44.93M | 41.91M | 32.40M | 27.14M | 22.87M | 24.25M |
| Other Operating Activities | -15.42M | -9.56M | -14.78M | 21.07M | -8.15M | -78.02M |
| Change in Accounts Receivable | -13.61M | 17.20M | -4.41M | 3.59M | -21.78M | -22.52M |
| Change in Inventory | -5.19M | -5.35M | 13.93M | 14.17M | 48.27M | -2.30M |
| Change in Accounts Payable | -3.75M | 6.72M | -11.28M | 5.06M | -707.00K | -5.83M |
| Change in Unearned Revenue | -555.00K | -222.00K | ||||
| Change in Other Net Operating Assets | 38.18M | -14.59M | -53.21M | -1.09M | -38.50M | 44.13M |
| Operating Cash Flow | 329.92M | 329.32M | 204.98M | 274.75M | 124.23M | 103.56M |
| Capital Expenditures | -1.64M | -1.74M | -1.65M | -461.00K | -1.62M | -1.94M |
| Cash Acquisitions | -655.40M | -267.54M | -572.07M | |||
| Investment in Securities | 105.14M | -61.79M | -18.57M | -70.35M | ||
| Investing Cash Flow | -551.90M | -63.53M | -287.76M | -70.81M | -573.69M | -1.94M |
| Long-Term Debt Issued | 565.17M | 325.00M | 241.50M | 517.68M | ||
| Long-Term Debt Repaid | -635.56M | -305.66M | -301.14M | -75.00M | -50.00M | |
| Net Debt Issued (Repaid) | 246.91M | -70.38M | 19.34M | -59.64M | 442.68M | -50.00M |
| Issuance of Common Stock | 5.10M | 5.64M | 11.07M | 9.10M | 12.15M | 12.71M |
| Repurchase of Common Stock | -17.90M | -37.95M | -79.19M | -83.36M | -18.11M | -52.01M |
| Other Financing Activities | -7.55M | -11.82M | -6.28M | |||
| Financing Cash Flow | 234.11M | -110.25M | -60.60M | -140.18M | 436.72M | -89.30M |
| Net Cash Flow | 12.13M | 155.55M | -143.38M | 63.76M | -12.74M | 12.31M |
| Free Cash Flow | 328.28M | 327.58M | 203.33M | 274.29M | 122.61M | 101.61M |
| Free Cash Flow Margin | 40.62% | 41.97% | 32.20% | 48.39% | 26.43% | 36.70% |
| Free Cash Flow Per Share | 9.07 | 8.25 | 5.03 | 6.56 | 3.62 | 2.48 |
| Levered Free Cash Flow | 324.04M | 321.54M | 362.08M | 264.87M | 70.53M | 109.21M |
| Unlevered Free Cash Flow | 367.29M | 367.65M | 402.30M | 308.32M | 101.75M | 118.93M |
| Cash Interest Paid | 67.65M | 68.76M | 62.43M | 73.26M | 52.53M | 17.61M |
| Cash Income Tax Paid | 65.24M | 60.04M | 52.09M | 24.20M | 10.40M | 3.00M |
| Change in Working Capital | 15.08M | 3.76M | -54.98M | 21.73M | -12.71M | 13.49M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 778.57M | 1.46B | 923.97M | 1.00B | 778.87M | 650.01M |
| Enterprise Value | 1.87B | 2.11B | 1.80B | 1.42B | 1.38B | 727.43M |
| Last Close Price | 23.80 | 46.30 | 28.65 | 30.78 | 23.20 | 18.68 |
| PE Ratio | 17.02 | 23.28 | 13.35 | 20.84 | 9.09 | |
| Forward PE | 3.37 | 6.11 | 4.54 | 5.57 | 4.01 | 4.57 |
| PS Ratio | 0.96 | 1.88 | 1.46 | 1.77 | 1.68 | 2.35 |
| PB Ratio | 2.48 | 4.85 | 4.04 | 5.14 | 4.00 | 3.20 |
| P/FCF Ratio | 2.36 | 4.47 | 4.54 | 3.66 | 6.35 | 6.40 |
| P/OCF Ratio | 2.35 | 4.44 | 4.51 | 3.65 | 6.27 | 6.28 |
| PEG Ratio | 0.67 | 0.16 | 0.16 | 0.16 | 0.17 | 1.08 |
| EV/Sales Ratio | 2.31 | 2.71 | 2.85 | 2.50 | 2.97 | 2.63 |
| EV/EBITDA Ratio | 4.60 | 5.04 | 4.87 | 4.37 | 7.99 | 7.98 |
| EV/EBIT Ratio | 10.85 | 10.95 | 9.00 | 8.08 | 36.13 | 32.76 |
| EV/FCF Ratio | 5.68 | 6.45 | 8.84 | 5.17 | 11.23 | 7.16 |
| Debt / Equity Ratio | 3.90 | 3.10 | 4.28 | 3.45 | 3.64 | 1.27 |
| Debt / EBITDA Ratio | 2.95 | 2.20 | 2.63 | 2.06 | 4.04 | 2.75 |
| Debt / FCF Ratio | 3.71 | 2.86 | 4.82 | 2.46 | 5.78 | 2.55 |
| Net Debt / Equity Ratio | 3.49 | 1.82 | 3.57 | 1.86 | 2.75 | 0.36 |
| Net Debt / EBITDA Ratio | 2.69 | 1.31 | 2.22 | 1.12 | 3.11 | 0.79 |
| Net Debt / FCF Ratio | 3.32 | 1.68 | 4.02 | 1.33 | 4.37 | 0.71 |
| Asset Turnover | 0.43 | 0.47 | 0.45 | 0.49 | 0.50 | 0.41 |
| Inventory Turnover | 1.13 | 2.27 | 2.46 | 2.41 | 3.70 | 3.58 |
| Quick Ratio | 0.70 | 1.36 | 0.77 | 1.07 | 0.82 | 1.04 |
| Current Ratio | 1.03 | 1.57 | 0.95 | 1.17 | 0.97 | 1.13 |
| Return on Equity (ROE) | 17.61% | 23.70% | 32.62% | 24.68% | -12.57% | 36.77% |
| Return on Assets (ROA) | 5.75% | 7.27% | 8.89% | 9.46% | 2.55% | 2.08% |
| Return on Invested Capital (ROIC) | 9.54% | 13.82% | 17.46% | 17.30% | 7.58% | 8.02% |
| Return on Capital Employed (ROCE) | 11.10% | 15.90% | 17.30% | 25.60% | 5.10% | 5.40% |
| Earnings Yield | 5.88% | 4.30% | 7.49% | 4.80% | -3.21% | 11.00% |
| FCF Yield | 42.37% | 22.38% | 22.01% | 27.33% | 15.74% | 15.63% |
| Buyback Yield / Dilution | 9.07% | 1.79% | 3.26% | -23.53% | 17.58% | -16.77% |